Purple BiotechPPBT
13F holders, Q4 2025 (December 31)1holders −2
0new positions
2sold out
$0.66avg. 13F price*
At the end of Q4 2025, 1 institutions reported holding Purple Biotech Ltd. (PPBT) in their 13F filings, down 2 from Q3 2025. 0 opened new positions and 2 sold out. The largest holder was EverSource Wealth Advisors, LLC ($37).
- Company
- Purple Biotech Ltd.
- CUSIP
- 74638P109
- Latest filing quarter
- Q4 2025
History
Number of 13F holders
Total Exit/New Position Q3 2025 → Q4 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 2 | $66 |
All 13F filers, Q3 2025 → Q4 2025: 114 shares sold, net −114 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 1 holders
| EverSource Wealth Advisors, LLC | 0.00% | No change | 56 | $37 |
"% of holder's portfolio" is PPBT's weight in each manager's 13F, not the share of Purple Biotech Ltd. the manager owns.